• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Mary Beth Scholand, MD

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
50 4.9 out of 5 Patient Rating

Languages Spoken: English

Dr. Mary Beth Scholand, MD is an associate professor in Pulmonary Medicine. Her research and clinical interest is Interstitial Lung Disease. This interest encompasses Idiopathic Pulmonary Fibrosis, Autoimmune Lung Diseases and Sarcoidosis. She is the Director of the Interstitial Lung Disease Clinic. She runs clinical trials focused on a cure for Idiopathic Pulmonary Fibrosis. In addition, her research focuses on phenotypic factors and genetic factors associated with Chronic Obstructive Pulmonary Diseases and Interstitial Lung Diseases.

Clinical Locations

Farmington Health Center

801-213-3200

165 N. University Ave.
Farmington, UT  84025
Map

South Jordan Health Center

801-213-4500

5126 West Daybreak Parkway
South Jordan, UT  84009
Map

Sugar House Health Center

801-581-2000

1280 E. Stringham Avenue
Salt Lake City, UT  84106
Map

University Hospital
Pulmonary, Clinic 3

801-581-7806

Fax: (801) 585-3555

50 N Medical Dr
Salt Lake City, UT  84132
Map

Specialties

  • Pulmonary Fibrosis
  • Advanced Lung Disease
  • Interstitial Lung Disease
  • Pulmonary
  • Sarcoidosis

Board Certification and Academic Information

Academic Departments Internal Medicine - Associate Professor
Academic Divisions Pulmonary
Board Certification American Board of Internal Medicine (Sub: Pulmonary Disease)
National Board of Medical Examiners

Patient Rating

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Learn About Our Survey

Likelihood of recommending care provider

4.9/ 5

Care provider's explanation of condition/problem

4.9/ 5

Care provider's effort to include me in decisions

4.9/ 5

Wait time at clinic

4.7/ 5

Care provider's concern for questions & worries

4.9/ 5

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

UofU Patient November 12, 2022
University Hospital

5 out of 5 stars

Dr. Scholand is a fantastic Doctor!!!! She listens, addresses any concerns, makes sure that at no time is there any questions left unanswered and is always very kind and explains everything so that you understand everything that is going on with your treatment and diagnosis.

UofU Patient October 30, 2022
Farmington Health Center

5 out of 5 stars

Have been with provider for awhile. Have good working relations .

UofU Patient October 28, 2022
South Jordan Health Center

5 out of 5 stars

She did a special good work

UofU Patient October 28, 2022
Sugar House Health Center

5 out of 5 stars

Dr. Scholand is excellent and very concerned with my health and will do anything she can to help.

UofU Patient October 16, 2022
FARMINGTON HEALTH CENTER

5 out of 5 stars

Excellent

UofU Patient October 16, 2022
FARMINGTON HEALTH CENTER

5 out of 5 stars

Dr Scholand was absolutely great!

UofU Patient October 08, 2022
FARMINGTON HEALTH CENTER

5 out of 5 stars

Dr. Scholand is the best when it comes to explaining and recommending treatments.

UofU Patient October 04, 2022
UH HOSPITALS AND CLINICS

5 out of 5 stars

Dr Scholand always listens well, explains well, and kindly answers all my questions. She also always includes me in decisions and formulating a plan. I REALLY appreciate her. I do wish the coordination that took place with my rheumatologist as it was when Dr. Frech was there was still in place. I think that was a huge benefit that is hard to replace when dealing with chronic, multi-faceted disease.

UofU Patient October 02, 2022
FARMINGTON HEALTH CENTER

4 out of 5 stars

Good

UofU Patient September 28, 2022
SOUTH JORDAN HEALTH CENTER

5 out of 5 stars

I have already told two others about. U of U. Lung Dept. They are going to contact the Hospital for help.

UofU Patient September 23, 2022
SUGAR HOUSE HEALTH CENTER

5 out of 5 stars

I'm so grateful to have found Dr Scholand. Her knowledge on my condition was so good. She explained things to me and included both my husband and I in decisions. She spoke to both of us. And really listened to both of us.

UofU Patient September 21, 2022
FARMINGTON HEALTH CENTER

5 out of 5 stars

I am a long time established patient of Dr. Scholand and she is a Great doctor as well as a special friend.

UofU Patient September 15, 2022
SOUTH JORDAN HEALTH CENTER

5 out of 5 stars

Dr Sholand is an amazing Dr I trust her completely. I feel she really cares about my care.

UofU Patient September 04, 2022
FARMINGTON HEALTH CENTER

5 out of 5 stars

Dr. Scholand always thinks of new ways or treatments to make my life easier.

UofU Patient August 28, 2022
FARMINGTON HEALTH CENTER

5 out of 5 stars

Outstanding doctor

UofU Patient August 12, 2022
SUGAR HOUSE HEALTH CENTER

5 out of 5 stars

Mary Beth is a wonderful, profesional and I really get in shock because she remembers things about me as a patient that I wasn't expecting. She is a very loving and graceful person that take car of patients not only with her knowledge, but with her heart. Great experience always!!!

UofU Patient August 06, 2022
SUGAR HOUSE HEALTH CENTER

4 out of 5 stars

I have had Dr. Scholand since I was 1st seen at the University of Utah over 12 years ago. She is the only reason I chose Healthy U as my provider. I could not see her under any other insurance option I had at the time. I have remained with Healthy U because it is great secondary insurance for me and I still have Dr. Scholand!!

UofU Patient August 04, 2022
SOUTH JORDAN HEALTH CENTER

5 out of 5 stars

Dr Scholand was excellent. Very knowledgeable, explained things thoroughly, very personable and compassionate. One of the best physician visits I've ever had. I'm so impressed with her efficiency snd follow through snd communication. 5 STAR

UofU Patient July 30, 2022
UH HOSPITALS AND CLINICS

5 out of 5 stars

Have been with this team since 2015.

UofU Patient July 21, 2022
UH HOSPITALS AND CLINICS

4 out of 5 stars

I wish I would have asked a few more questions

UofU Patient July 17, 2022
FARMINGTON HEALTH CENTER

5 out of 5 stars

Very satisfied

UofU Patient July 16, 2022
UH HOSPITALS AND CLINICS

5 out of 5 stars

Dr Scholand is amazing

UofU Patient July 14, 2022
UH HOSPITALS AND CLINICS

4 out of 5 stars

Good

UofU Patient July 01, 2022
SUGAR HOUSE HEALTH CENTER

5 out of 5 stars

Dr. Scholand went all out to answer all my questions and to calm my concerns. She made sure I was part of the future plans by encouraging my input. I am extremely happy with my experiences with her.

UofU Patient June 23, 2022
SOUTH JORDAN HEALTH CENTER

5 out of 5 stars

Pharmacy was very helpful

UofU Patient June 22, 2022
SUGAR HOUSE HEALTH CENTER

5 out of 5 stars

The physician is very patient centered in her care delivery.

UofU Patient June 07, 2022
SUGAR HOUSE HEALTH CENTER

5 out of 5 stars

Dr. Scholand is one of the most caring doctors I have ever met.

UofU Patient June 04, 2022
SUGAR HOUSE HEALTH CENTER

4 out of 5 stars

I am glad I decided to seek out another opinion from her. She is very knowledgeable and wants to get to cause of fibrosis so she can select best possible treatment.

UofU Patient May 29, 2022
FARMINGTON HEALTH CENTER

5 out of 5 stars

Good

Dr. Mary Beth Scholand, MD is an associate professor in Pulmonary Medicine. Her research and clinical interest is Interstitial Lung Disease. This interest encompasses Idiopathic Pulmonary Fibrosis, Autoimmune Lung Diseases and Sarcoidosis. She is the Director of the Interstitial Lung Disease Clinic. She runs clinical trials focused on a cure for Idiopathic Pulmonary Fibrosis. In addition, her research focuses on phenotypic factors and genetic factors associated with Chronic Obstructive Pulmonary Diseases and Interstitial Lung Diseases.

Academic Locations

Research Statement

Dr. Mary Beth Scholand is an Associate Professor in Pulmonary Medicine. Her clinical practice primarily focuses on interstitial lung disease (ILD) and she is the Director of the ILD Clinic. ILD is a disease category that encompasses many pulmonary conditions, including idiopathic pulmonary fibrosis (IPF), autoimmune lung diseases, and sarcoidosis. Dr. Scholand is the principal investigator on numerous clinical trials which aim to find a treatment for pulmonary fibrosis (both idiopathic and autoimmune in etiology), and is a co-investigator in NIH-funded studies on IPF and chronic obstructive pulmonary disease. In addition, Dr. Scholand studies the relationship between genetic and phenotypic variation to identify genes that significantly elevate the risk of developing ILD, and thus to find new therapeutic targets.

Board Certification and Academic Information

Academic Departments Internal Medicine - Associate Professor
Academic Divisions Pulmonary
Board Certification American Board of Internal Medicine (Sub: Pulmonary Disease)
National Board of Medical Examiners

Research Interests

  • Pulmonary Fibrosis

Education History

Fellowship University of Utah School of Medicine
Pulmonary Medicine
Fellow, 2002
Residency Barnes Hospital
Internal Medicine
Resident, 1993
Internship Barnes Hospital
Internal Medicine
Intern, 1991
Professional Medical Washington University
Medicine
M.D., 1990
Undergraduate Northwestern University

B.S., 1986

Selected Publications - Journal Articles

Journal Article

  1. Saketkoo LA LA, Jensen K, Nikoletou D, Newton JJ, Rivera FJ, Howie M, Reese RK, Goodman M, Hart PB, Bembry W, Russell A, Lian I, Lammi MR, Scholand Mb MB, Russell Am AM (2022). Sarcoidosis Illuminations on Living During COVID-19: Patient Experiences of Diagnosis, Management, and Survival Before and During the Pandemic. J Patient Exp, 9, 23743735221075556.
  2. Lee J, White E, Freiheit E, Scholand MB, Strek ME, Podolanczuk AJ, Patel NM, Pulmonary Fibrosis Foundation (2022). Cough-specific Quality of Life Predicts Disease Progression Among Patients with Interstitial Lung Disease: Data from the Pulmonary Fibrosis Foundation Patient Registry. Chest.
  3. Gupta R, Baughman RP, Nathan SD, Wells AU, Kouranos V, Alhamad EH, Culver DA, Barney J, Carmona EM, Cordova FC, Huitema M, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Price LC, Wort SJ, Shlobin OA (2022). The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry. Respir Med, 196, 106801.
  4. Rahaghi FF, Kolaitis NA, Adegunsoye A, de Andrade J, Flaherty KR, Lancaster L, Lee JS, Levine D, Preston IR, Safdar Z, Saggar R, Sahay S, Scholand MB, Shlobin O, Zisman DA, Nathan SD (2022). Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study. Chest, 162, 145-155.
  5. Huitema MP, Post MC, Grutters JC, Wells AU, Kouranos V, Shlobin OA, Nathan SD, Culver DA, Barney J, Gupta R, Carmona E, Alhamad EH, Scholand MB, Wijsenbeek M, Ganesh S, Lower EE, Engel PJ, Baughman RP (2022). Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study. Sarcoidosis Vasc Diffuse Lung Dis, 38(4), e2021032.
  6. Lasky JA, Case A, Unterman A, Kreuter M, Scholand MB, Chaudhary S, Lofaro LR, Johnson M, Huang J, Bhorade SM, Kennedy GC (2021). The Impact of the Envisia Genomic Classifier in the Diagnosis and Management of Patients with Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc, 19, 916-924.
  7. Pettersson H, Alexanderson H, Poole JL, Varga J, Regardt M, Russell AM, Salam Y, Jensen K, Mansour J, Frech T, Feghali-Bostwick C, Varj C, Baldwin N, Heenan M, Fligelstone K, Holmner M, Lammi MR, Scholand MB, Shapiro L, Volkmann ER, Saketkoo LA (2021). Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS). Best Pract Res Clin Rheumatol, 35, 101695.
  8. Saketkoo LA, Russell AM, Jensen K, Mandizha J, Tavee J, Newton J, Rivera F, Howie M, Reese R, Goodman M, Hart P, Strookappe B, De Vries J, Rosenbach M, Scholand MB, Lammi MR, Elfferich M, Lower E, Baughman RP, Sweiss N, Judson MA, Drent M (2021). Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes. Diagnostics (Basel), 11(6).
  9. Martinez FJ, Yow E, Flaherty KR, Snyder LD, Durheim MT, Wisniewski SR, Sciurba FC, Raghu G, Brooks MM, Kim DY, Dilling DF, Criner GJ, Kim H, Belloli EA, Nambiar AM, Scholand MB, Anstrom KJ, Noth I, CleanUP-IPF Investigators of the Pulmonary Trials Cooperative (2021). Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial. JAMA, 325(18), 1841-1851.
  10. Maher TM, Costabel U, Glassberg MK, Kondoh Y, Ogura T, Scholand MB, Kardatzke D, Howard M, Olsson J, Neighbors M, Belloni P, Swigris JJ (2021). Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis. Eur Respir J, 57(2).
  11. Richeldi L, Scholand MB, Lynch DA, Colby TV, Myers JL, Groshong SD, Chung JH, Benzaquen S, Nathan SD, Davis JR, Schmidt SL, Hagmeyer L, Sonetti D, Hetzel J, Criner GJ, Case AH, Ramaswamy M, Calero K, Gauhar UA, Patel NM, Lancaster L, Choi Y, Pankratz DG, Walsh PS, Lofaro LR, Huang J, Bhorade SM, Kennedy GC, Martinez FJ, Raghu G (2020). Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia. Am J Respir Crit Care Med, 203(2), 211-220.
  12. Swigris JJ, Andrae DA, Churney T, Johnson N, Scholand MB, White ES, Matsui A, Raimundo K, Evans CJ (2020). Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire. Am J Respir Crit Care Med, 202(12), 1689-1697.
  13. Rahaghi FF, Safdar Z, Brown AW, de Andrade JA, Flaherty KR, Kaner RJ, King CS, Padilla ML, Noth I, Scholand MB, Shifren A, Nathan SD (2020). Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus study. BMC Pulm Med, 20(1), 191.
  14. Baughman RP, Scholand MB, Rahaghi FF (2020). Clinical phenotyping: role in treatment decisions in sarcoidosis. Eur Respir Rev, 29(155).
  15. Rahaghi FF, Baughman RP, Saketkoo LA, Sweiss NJ, Barney JB, Birring SS, Costabel U, Crouser ED, Drent M, Gerke AK, Grutters JC, Hamzeh NY, Huizar I, Ennis James W 4th, Kalra S, Kullberg S, Li H, Lower EE, Maier LA, Mirsaeidi M, Mller-Quernheim J, Carmona Porquera EM, Samavati L, Valeyre D, Scholand MB (2020). Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. Eur Respir Rev, 29(155).
  16. Rahaghi FF, Sweiss NJ, Saketkoo LA, Scholand MB, Barney JB, Gerke AK, Lower EE, Mirsaeidi M, OHare L, Rumbak MJ, Samavati L, Baughman RP (2020). Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study. Eur Respir Rev, 29(155).
  17. Saketkoo LA, Scholand MB, Lammi MR, Russell AM (2020). Patient-reported outcome measures in systemic sclerosis-related interstitial lung disease for clinical practice and clinical trials. J Scleroderma Relat Disord, 5(2 Suppl), 48-60.
  18. Richeldi L, Fernndez Prez ER, Costabel U, Albera C, Lederer DJ, Flaherty KR, Ettinger N, Perez R, Scholand MB, Goldin J, Peony Yu KH, Neff T, Porter S, Zhong M, Gorina E, Kouchakji E, Raghu G (2019). Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Respir Med, 8(1), 25-33.
  19. Patel NM, Kulkarni T, Dilling D, Scholand MB, Interstitial and Diffuse Lung Disease Network Steering Committee (2019). Preoperative Evaluation of Patients With Interstitial Lung Disease. Chest, 156(5), 826-833.
  20. Wuyts W, Antin-Ozerkis D, Huggins JT, LaCamera PP, Spagnolo P, Vakov M, Wijsenbeek MS, Polman B, Kirchgaessler KU, Scholand MB (2019). Serious adverse events in patients with idiopathic pulmonary fibrosis in the placebo arms of 6 clinical trials. Respir Med, 150, 120-125.

Review

  1. Saketkoo LA, Frech T, Varj C, Domsic R, Farrell J, Gordon JK, Mihai C, Sandorfi N, Shapiro L, Poole J, Volkmann ER, Lammi M, McAnally K, Alexanderson H, Pettersson H, Hant F, Kuwana M, Shah AA, Smith V, Hsu V, Kowal-Bielecka O, Assassi S, Cutolo M, Kayser C, Shanmugam VK, Vonk MC, Fligelstone K, Baldwin N, Connolly K, Ronnow A, Toth B, Suave M, Farrington S, Bernstein EJ, Crofford LJ, Czirjk L, Jensen K, Hinchclif M, Hudson M, Lammi MR, Mansour J, Morgan ND, Mendoza F, Nikpour M, Pauling J, Riemekasten G, Russell AM, Scholand MB, Seigart E, Rodriguez-Reyna TS, Hummers L, Walker U, Steen V (2021). A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc. [Review]. Best Pract Res Clin Rheumatol, 35(3), 101707.

Case Report

  1. Werst D, Scarpato B, Callahan SJ, Scholand MB (2020). A 64-Year-Old Man With Multifocal Infiltrates. Chest, 159(3), e151-e154.

Letter

  1. Saketkoo LA, Alexanderson H, Lammi MR, LeSage D, Jensen K, Scholand MB, Volkmann ER, Russell AM (2020). An ode to the primal tonic of dance-congratulating the Life of Breath project. [Letter to the editor]. Lancet Respir Med, 8(12), e90-e91.

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Price Estimate
  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

Appointment Scheduling:
801-213-9500

Hospital Operator:
801-581-2121

En Español:
801-646-5914

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2023 University of Utah Health